COMMUNIQUÉS West-GlobeNewswire
-
Resolutions of the Annual General Meeting
24/04/2026 -
Alvotech to Report Financial Results for the First Quarter of 2026
24/04/2026 -
ACTG Launches Landmark Study Evaluating Treatments for Depressive Disorders with or without Mild Neurocognitive Disorder among People Living with HIV
24/04/2026 -
Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML
24/04/2026 -
Oncotelic Therapeutics Provides Corporate Update on Partnership Strategy
24/04/2026 -
Acentra Health Chief AI Officer Sean Harrison Named to NVTC AI50
24/04/2026 -
The Genius Song & The Brain Song Official 2026: 7-Second Brain Trick’ Genius Brainwave Music to Improve Focus and memory By Genius wave?
24/04/2026 -
Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder
24/04/2026 -
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24/04/2026 -
Alvotech to Report Financial Results for the First Quarter of 2026
24/04/2026 -
Jushi Holdings Inc. Announces Proposed Continuance from British Columbia to Nevada
24/04/2026 -
A.D.A.M. Innovations Unveils GeneLock™: The World’s First Genetic Data Protection Platform
24/04/2026 -
Media Advisory-Ontario Health Coalition/Large cross-province protests this Saturday: Ford gov’t pushing our hospitals into deficit & cuts while paying more to privatize their services
24/04/2026 -
Medicana Health Group Launches HPV Vaccination and Cervical Cancer Awareness Campaign, Advancing Prevention Through Regular Check-Ups
24/04/2026 -
Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026
24/04/2026 -
Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess®
24/04/2026 -
DNA DAY™ 2026: GeneLife Advances GeneAI Forecast with 15 Predictive Models and Enhanced Lifestyle Integration
24/04/2026 -
2025 Annual Report Vistin Pharma ASA
24/04/2026 -
ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET
24/04/2026
Pages